These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34478246)

  • 1. Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification.
    Pedersen KW; Hansen J; Hasselstrøm JB; Jornil JR
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00860. PubMed ID: 34478246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmortem protein stability investigations of the human hepatic drug-metabolizing cytochrome P450 enzymes CYP1A2 and CYP3A4 using mass spectrometry.
    Hansen J; Palmfeldt J; Pedersen KW; Funder AD; Frost L; Hasselstrøm JB; Jornil JR
    J Proteomics; 2019 Mar; 194():125-131. PubMed ID: 30529742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and Lifestyle-Related Factors are Associated with Altered Hepatic CYP Protein Levels in People Diagnosed with Mental Disorders.
    Pedersen KW; Hansen J; Banner J; Hasselstrøm JB; Jornil JR
    Drug Metab Dispos; 2023 Sep; 51(9):1169-1176. PubMed ID: 37258304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry [corrected].
    Achour B; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2011 Nov; 39(11):2130-4. PubMed ID: 21795467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry.
    Seibert C; Davidson BR; Fuller BJ; Patterson LH; Griffiths WJ; Wang Y
    J Proteome Res; 2009 Apr; 8(4):1672-81. PubMed ID: 19714871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes.
    Meakin AS; Amirmostofian M; Darby JR; Holman SL; Morrison JL; Wiese MD
    Placenta; 2023 Jan; 131():82-89. PubMed ID: 36527743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative protein determination for CYP induction via LC-MS/MS.
    Williamson BL; Purkayastha S; Hunter CL; Nuwaysir L; Hill J; Easterwood L; Hill J
    Proteomics; 2011 Jan; 11(1):33-41. PubMed ID: 21182192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens.
    Wenzel C; Drozdzik M; Oswald S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122891. PubMed ID: 34390906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 inhibition activities of non-standardized botanical products.
    Abduraman MA; Mustafa NH; Yaacob NS; Amanah A; Tan ML
    J Ethnopharmacol; 2022 Oct; 296():115406. PubMed ID: 35659627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.
    Stewart NA; Buch SC; Conrads TP; Branch RA
    Analyst; 2011 Feb; 136(3):605-12. PubMed ID: 21107456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of Bovis Calculus Artifactus on eight rat liver cytochrome P450 isozymes using LC-MS/MS and cocktail approach.
    Zhang YJ; Zhou WL; Yu F; Wang Q; Peng C; Kan JY
    Xenobiotica; 2021 Sep; 51(9):1010-1018. PubMed ID: 34294011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine.
    Puris E; Pasanen M; Gynther M; Häkkinen MR; Pihlajamäki J; Keränen T; Honkakoski P; Raunio H; Petsalo A
    Anal Bioanal Chem; 2017 Jan; 409(1):251-268. PubMed ID: 27734142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute Quantitation of Drug-Metabolizing Cytochrome P450 Enzymes and Accessory Proteins in Dog Liver Microsomes Using Label-Free Standard-Free Analysis Reveals Interbreed Variability.
    Martinez SE; Shi J; Zhu HJ; Perez Jimenez TE; Zhu Z; Court MH
    Drug Metab Dispos; 2019 Nov; 47(11):1314-1324. PubMed ID: 31427433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive expression of cytochrome P450 in foetal and adult porcine livers-Effects of body weight.
    Rasmussen MK; Theil PK; Oksbjerg N
    Toxicol Lett; 2016 Sep; 258():87-92. PubMed ID: 27320961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5.
    Wiercinska P; Squires EJ
    Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis.
    An XX; Yu Y; Li GF; Yu G
    Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):225-233. PubMed ID: 33368014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis /LC-MS/MS.
    Zambon S; Fontana S; Kajbaf M
    Drug Metab Lett; 2010 Aug; 4(3):120-8. PubMed ID: 20642444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
    Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.